Endoscopic stent for palliating malignant and benign biliary obstruction

Enns RA. Expandable biliary stents: more questions than answers[J]. Am J Gastroenterol 2000; 95: 575–7.

Qin LX, Tang ZY. Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis[J]. World J Gastroenterol 2003; 9: 385–91.

van Leeuwen DJ, Reeders JW. Primary sclerosing cholangitis and cholangiocarcinoma as a diagnostic and therapeutic dilemma[J]. Ann Oncol 1999; 10(Suppl 4): 89–93.

Torok N, Gores GJ. Cholangiocarcinoma[J]. Semin Gastrointest Dis 2001; 12: 125–32.

Bain VG, Abraham N, Jhangri GS, et al. Prospective study of biliary strictures to determine the predictors of malignancy[J]. Can J Gastroenterol 2000; 14: 397–402.

Gong B, Zhou DY. Analysis of endoscopy bile duct drainage in 375 patients[J]. Chin J Digest Endosc 1995; 12: 77.

Cheng JL, Bruno MJ, Bergman JJ, et al. Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents[J]. Gastrointerst Endosc 2002; 56: 33–9.

Dinkel HP, Triller J. Primary and long-term success of percutaneous biliary metallic endoprotheses (Wallstents) in malignant obstructive jaundice[J]. Rofo Fortschr Geb Rontgenstr N euen Bildged Verfahr 2001; 173: 1072–8.

Manolakopoulos S, Avgerinos A, Vlachogiannakos J, ET AL. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial[J]. Gastrointest Endosc 2002; 55: 470–5.

Poon RT, Fan ST. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results[J]. JOP 2003; 4: 33–40.

Davids PHP, Groen AK, Rauws EA, et al. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction[J]. Lancet 1992; 340: 1488–92.

Schmassmann A, Von Gunten E, Knuchel J, et al. Wallstents versus plastic stents in malignant biliary obstruction: Effects of stent patency of the first and second stent on patient compliance and survival[J]. Am J Gastroenterol 1996; 91: 654–9.

Prat F, Chapat O, Ducot B, et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct[J]. Gastrointest Endosc 1998; 47: 1–7.

Sheperd HA, Royle G, Ross APR, et al. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct-a randomized trial[J]. Br J Surg 1988; 75: 1166–8.

Hatzidakis AA, Tsetis D, Chrysou E, et al. Nitinol stents for palliative treatment of malignant obstructive jaundice: should we stent the sphincter of Oddi in every case[J]? Cardiovasc Intervent Radiol 2001; 24: 245–8.

De Palma GD, Galloro G, Iuliano G, et al. Leaks from laparoscopic cholecystectomy[J]. Hepatogastroenterology 2002; 49: 924–5.

De Palma GD, Iuliano GP, Puzziello A, et al. Biliary leaks after laparoscopic cholecystectomy. Results of the endoscopic treatment[J]. Minerva Chir 2002; 57: 123–7.

Reed DN Jr, Vitale GC, Wrightson WR, et al. Decreasing mortality of bile leaks after elective hepatic surgery[J]. Am J Surg 2003; 185: 316–8.

Bhattacharjya S, Puleston J, Davidson BR, et al. Outcome of early endoscopic biliary drainage in the management of bile leaks after hepatic resection[J]. Gastrointest Endosc 2003; 57: 526–30

Sugiyama M, Izumisato Y, Abe N, et al. Endoscopic biliary stenting for treatment of bile leakage after hepatic resection[J]. Hepatogastroenterology 2001; 48: 1579–81.

De Palma GD, Galloro G, Sicicliano S, et al. Endoscopic stenting for definitive treatment of irretrievable common bile duct calculi. A long-term follow-up study of 49 patients[J]. Hepato- gastroenterology 2001; 48: 56–8.